The Dutch Multiplier Event on HR4Homelessness

On the 29th of July, De Regenboog Groep / C-EHRN hosted the webinar “Improving Harm Reduction Services for People Who use Substances in the situation of Homelessness”. This webinar is part of the Eramus+ project “HR4Homelessness”.

With 40 registered participants, the event brought together professionals working in homelessness and drug use to exchange experiences about their harm reduction programmes, the challenges they face, the successes, and to get acknowledged with the outcomes of the HR4Homeless project.

Roberto Perez Gayo, policy officer at C-EHRN, presented the overall aim and specific objectives of the project and the contribution of the activities and outputs. Specifically, the event offered the participants the possibility of getting acquittanced with two critical project outcomes. On the one hand, attention was given to the Harm Reduction Key Principles and how they can help homeless services improving harm reduction provision for people who use drugs. On the other, to the outcomes of the EU-wide survey on harm reduction service provision that project developed. Ruth Kasper, HR4Homelessness project coordinator, presented data regarding current HR provision for people experiencing homelessness and the synthesis of drug/alcohol use among people in situations of homelessness and their access to support services in the partner countries.

The project and outcomes presentation was followed by three projects that put forward the diversity of approaches to harm reduction and recent development they work to respond to. First, Vivienne Blommendaal and Frank van Milt, caseworkers at the Centre of Expertise Housing First HVO Querido, shared with participants the relationship between Housing First and Harm Reduction models. Both Vivienne and Frank provided insights into how HR works within their project and some of the practical implications for adequate support of people who use drugs in Housing First programmes. Next, Ingrid Bakker – projects officer at MAINline – presented ‘Omgaan met Verward Gedrag”, a recent project that seeks to increase the capacity of low-threshold facilities & their staff to respond to neural diversity. In recent years the Netherlands has experienced a rise in homelessness, while at the same time problems in capacity on shelters and mental health facilities. Already for a while, MAINline was receiving signals from shelters themselves that they were working with people with more complex needs of support – substance dependence, mental health, homelessness, among others -, and that their capacity to respond adequately to it was limited. In response to this situation, “Omgaan met Verward Gedrag” has developed a manual and a training programme to build the capacity of service providers in the field of homelessness. After this, Sonja Groot – De Regenboog / Amsterdam Undeground – presented the community-led projects she works on: a tour guiding company that operates as a community-led cooperative. Amsterdam Undeground functions not only as a labour integration and community building project for and by people who use(d) drugs but also as a platform for advocacy and fighting stigma. Through their own experiences, the guides can give insight into the lives of people who use drugs, people experiencing homelessness or sex workers, among others.

For any further information, please contact Roberto Perez Gayo rpgayo@correlation-net.org

 

#HepatitisCantWait … neither should we

Today is World Hepatitis Day, #WHD21. Every year on 28th July, civil society organisations, among many others, call on people from across the world to take action and raise awareness of hepatitis. This year’s campaign is another valid point, also acclaimed by WHO: #HepatitisCantWait.

With a person dying every 30 seconds from a hepatitis-related illness, people affected by hepatitis cannot wait to end stigma and discrimination especially now that the current #COVID19 crisis negatively affected hepatitis testing and treatment, leaving many more people unaware and unassisted.
How can health inclusion be exempt from agendas, one wonders?

According to our Monitoring Report 2020, persistent stigmatisation and restrictive policies towards drug use are some of the roughest feeders of deprived, vulnerable communities.
How can countries wait for further harmful facts whilst an inclusive continuum of health care guarantees stronger and more equal societies? 

National guidelines for HCV testing and treatment must include people who use drugs (PWUD) as well as people who inject drugs (PWID) and must allow for low threshold and community-based care to positively impact a #HepFreeFuture states the Monitoring Report 2020 Executive Summary.
How can governments wait to trigger more inclusive health regulations?

Our 2019 briefing paper “HCV in People Who Use Drugs: results from civil society monitoring in Europe” concluded that the main barriers to address HCV among PWID include a lack of funding, knowledge, awareness, dedicated health workers, political support in general, as well as weakness of CSOs and legal barriers.
How can the hands of European Health NGOs’ be tied with existential struggles; shouting #BringBackOperatingGrants whilst #EU4HealthNGOs is the obvious path to take?

The ongoing pandemic has proven all healthcare gaps to remain resolutely in place. If we are to #EliminateHepatitis by 2030, we urgently need to focus on community-led and community-based preventions, #HealthInclusion, testing and treatment.

Let us work collectively for a future where hepatitis was a joke of the past.
Visit worldhepatitisday.org and see how you can get involved for such a future.
Because #HepatitisCantWait, neither should we.

A Feasibility Study to Increase Chronic Hepatitis C Virus RNA Testing and Linkage to Care among Clients Attending Homeless Services in Amsterdam, The Netherlands

People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV) infections and are frequently homeless. To improve HCV case finding in these individuals, the authors examined the feasibility of rapid HCV RNA testing in homeless services in Amsterdam. In 2020, they provided a comprehensive service to homeless facilities, including workshops on HCV for personnel, a “hepatitis ambassador” at each facility, a rapid, onsite HCV RNA fingerstick test service, and assistance with linkage to care.

One of the authors’ points is that screening in homeless services with rapid testing is feasible and could improve HCV case finding for PWID who do not regularly attend primary care or other harm reduction services for people who use drugs.

The study was published at Diagnostics, an international, peer-reviewed, open-access journal on medical diagnosis published monthly online by MDPI.

Read the study here

Briefing Paper: Treatment, prevention and harm reduction interventions for different forms of ATS use

This policy brief aims at contributing to the reduction of the harms of ATS use by describing different trajectories of ATS use and offering a set of evidence-based interventions for different groups of ATS users. The different ATS trajectories are based on qualitative findings of large multinational research, the ATTUNE study, conducted between February and August 2017 in five European countries – the Netherlands, UK, Germany, Poland and the Czech Republic. The evidence-based interventions recommended in this brief are based on a literature review. In this document, both ATS trajectories and interventions from previous studies/programmes are combined to propose tailor-made recommendations for people who use ATS and those providing services to them.

The following sections in this brief describe:
1. The different types of ATS and the context of their use in Europe;
2. The various ATS use trajectories that ATTUNE study participants have experienced;
3. A set of evidence-based interventions to prevent, treat and reduce the harms caused by ATS use; and,
4. Recommendations for policymakers, practitioners and others working with drug-related services.

Read more

Support.Don’t.Punish.: The burning need for an approach that rejects the violence of criminalisation

As the 2021 Global Day of Action on 26th June approaches, the sudden realisation of the end of the first half of the year hits agendas as well. It states the need for creating more realistic resolution checklists boldly. It is the same sidestepping for everyone, from individuals to governments.

What is said vs What is done and What ought to be.

50 years ago, when the United States launched their #WarOnDrugs, their recreational checklist has triggered a series of tragic events that defined the decades until to this day. Evidence and empathy have been parked firmly whilst a backdrop of political expediency and bigotry took on the stage. Conclusion? Marginalisation, extremism, criminalisation, punishment and stigmatisation rather than advancing our communities’ health, human rights and well-being.

Every year, on 26th June, the Support.Don’t.Punish. campaign mobilises in reaction to this violence and this loss to build sustainable alternatives. Even last year, despite the Covid-19 pandemic, the mobilisation took place with the same spirit of care and determination.

This year will be no exception.

Below is a list of things you can do and share:

Share information
Support.Don’t.Punish. channels will be sharing regular information to prompt reflection and action.
Follow and share 
FacebookTwitterInstagram and the Day of Action’s website.

Join the Photo Project
With over 10,000 entries, the Photo Project is proof of global solidarity. Not yet in there? Print the logo, snap a photo and send it over by e-mail. Invite your networks and colleagues to do so too.

Organise & mobilise!
From big conferences to mural-painting to small ‘open house’ days, there are quite literally hundreds of ways to join the Day of Action. Check the campaign’s Bank of Ideas for Mobilisation for inspiration and make sure you are part of the ‘Supporting organisations’ list.

Plan your mobility action now and join the crowds to make the message louder and stronger.
Let’s #UndoTheWar

Open call for writers and editors to support us in our upcoming publications.

We are looking for qualified experts for the writing of each of the following briefing papers:

1. Drug Consumption Rooms in Europe 

The Paper should provide an update on the existing evidence and practice in the European region and describe advocacy efforts of countries to promote and support the development of Drug Consumption Rooms in their country. This Briefing Paper will be linked to discussions within the International Network of Drug Consumption Rooms (INDCR) and should be based on a literature review and expert interviews.

 

2. Addressing the harm reduction funding crisis in Romania

The Paper should provide an overview of the current funding crisis and the challenges in providing harm reduction services in Romania and analysing existing challenges. The Paper should be based on literature and interviews with various stakeholders in the field.

 

3. Addressing harm reduction in prisons

The Paper should be based on the data collected in the framework of the C-EHRN civil society monitoring and literature on the topic.
The briefing papers’ volumes are planned to be 8-12 pages, and their deadline is due October 2021.The applications should contain a short description and references of the applicant’s skills and expertise in the related area of choice of topic.
Please send your application to kschiffer@correlation-net.org and eschatz@correlation-net.org before the 18th of June.

 

4. We are also looking for qualified editors to review and edit different C-EHRN publications, papers and reports.

Pay attention! This open call refers to different C-EHRN publications.
The applications should contain a short description and references of the applicant’s skills and expertise in the related area of choice of topic.
Please send your application to kschiffer@correlation-net.org and eschatz@correlation-net.org before the 18th of June.

We are looking forward to hearing from you.
Thank you so much for your time, and Good luck with your application!

Warm Regards,
C-EHRN team

Future Collaboration for Harm Reduction in Europe

Last month, we organised two meetings welcoming the national harm reduction networks in Europe who have taken part in our recently published survey. As networking is one of our strengths, and we would like to initiate closer collaborations within the harm reduction networks in Europe, we were thrilled to start the dialogue.

The attending organisations’ backgrounds varied from self-support to peer-led harm reduction, to research-based services, to intersectional cooperation and finally to non-governmental and somewhat illegal provision. Their culturally spiced struggles were not only very inspiring but also familiar.

The critical points of these meetings were to discuss how we could support each other and help advocate together. We believe that advocacy could easily be one of the grounds to meet and provide insights to others dealing with similar challenges. Don’t you agree?

We have now set up a news wheel in our newsletter where each edition will bring you updates from Europe-wide countries.
Any thoughts you would like to share?
Please send us an email to administration@correlation-net.org.

Interview with Peter Sarosi

Can you tell us about your background?

I don’t like the term “expert” so I just say I am an activist working in the field of drug policy reform advocacy. I am recently the director of the Rights Reporter Foundation, a small human rights NGO based in Budapest, and the chief editor of the Drugreporter website.

How would you describe your work in general?

What we try to do is to change policies and public attitudes on drugs and people who use them. We create contents such as online articles, blogs and videos to educate the public about the alternatives of current punitive drug policies, we advise decision makers, we document human rights abuses, we make the drug control system more transparent and accountable and we train and empower other professionals and activists to make their voices heard.

What drives you personally to work in your area of work?

I am a humanist in the sense how Thomas Mann defined this word: I love justice, freedom, knowledge, patience, humility, joy and doubt. For me, this is not only a profession but a lifestyle and philosophy too, I cannot breathe without trying to fight for these values. Not only for myself, but for those who are marginalised and excluded from society.

What is your current focus?

Usually, I work on many things simultaneously. But one of the questions that always kept me thinking is how social attitudes on drug policies are formed and how can we change them. I’ve just started my PhD at the ELTE university in Budapest, so now I will have an opportunity to research this question.

Why do you think that your current focus is important?

Because this is a key question for advocacy. We have been trying so many methods and tools to convince the public that harm reduction works or that we shouldn’t punish people for what they put into their own bodies. Some of them seemed to work, some of them didn’t, but still, we know very little about what arguments, messages are convincing and how they can change people’s attitudes to drugs.

Harm reduction is still underfunded in many countries, even if there is enough evidence that it works and is cost-effective. Why is that?

Tolstoy famously said “happy families are all alike; every unhappy family is unhappy in its own way.” Well, by filming about harm reduction in so many countries of the world, I have learnt that this is true for harm reduction in individual countries or cities. In some countries for example, it is simply lack of resources and commitment to support public health and social care in general. In other countries it is not about the lack of money but there is a very strong ideological opposition to harm reduction. And there are cities where the NIMB (not in my backyard) attitudes obstruct harm reduction. But at the core of these problems we always find the inequality and injustice of the societies we live in, the desire of the powerful to discipline and punish the poor and powerless and manipulate society with fearmongering.

Please tell us what harm reduction means to you.

I define it as the philosophy and practice of compassionate pragmatism. In regard to drugs and people who use them it means that we have to support people who use drugs where they are at, as citizens in need of help, with non-judgmental interventions that respect human rights and are based on evidence. Although harm reduction, as a term, is a double negation, it is important to recognize that what we fight for is not only “reducing harms” but to help individuals and communities to live in dignity, freedom and solidarity.